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CLINICAL CASE

IGA VASCULITIS (HENOCH SCHÖNLEIN PURPURA)
IN A PEDIATRIC PATIENT WITH COVID-19 AND
STRONGYLOIDIASIS. CASE REPORT
VASCULITIS POR IGA (PÚRPURA DE HENOCH SCHÖNLEIN) EN UN PACIENTE PEDIÁTRICO CON COVID-19 Y
ESTRONGILOIDIASIS. REPORTE DE CASO
Mayron D. Nakandakaria,1, Hamilton Marín-Macedob,2, Raúl Seminario-Vilcab,2

CLINICAL CASE

ABSTRACT
Vasculitis is a rare disease in children, with IgA Vasculitis being its most common presentation. One
condition that is not yet under-researched is the likely association of IgA vasculitis-like processes with
SARS-CoV-2 infection. It is presented the case of a four-year-old patient who healed with palpable purplish
lesions to lower limb predominance, acute abdominal pain, and episodes of high digestive hemorrhage.
Initially listed as a possible severe dengue and leptospirosis, but clinically and laboratorially associated
with IgA vasculitis. It was SARS-CoV-2 IgM and IgG: Reactive. And in parasitological study was identified
Strongyloides stercoralis. Symptomatology subsided after administration of corticotherapy and the
evolution was favorable. In conclusion, it was presented a rare case in the pediatric population, probably
associated with the still unknown effects and damage of COVID-19 in the current pandemic.
Key words: Vasculitis; Henoch Schönlein purpura; Coronavirus; Strongyloidiasis; Pediatrics (source: MeSH NLM).

RESUMEN
La vasculitis es una enfermedad rara en los niños, siendo la Vasculitis por IgA su presentación más
frecuente. Una condición aún poco investigada, es la probable asociación de los procesos tipo vasculitis
por IgA con la infección por SARS-CoV-2. Se presenta el caso de una paciente de cuatro años que cursó
con lesiones purpúricas palpables a predominio de miembros inferiores, dolor abdominal agudo, y
episodios de hemorragia digestiva alta. Inicialmente catalogado como un posible dengue grave y
leptospirosis, pero que clínica y laboratorialmente se asoció a un cuadro de vasculitis por IgA. Fue SARSCoV-2 IgM e IgG: Reactivo. Y tuvo coproparasitológico en el que se identificó al Strongyloides stercoralis.
La sintomatología remitió tras la administración de corticoterapia y la evolución fue favorable. Como
conclusión, se expuso un caso infrecuente en la población pediátrica, probablemente asociado a los
efectos y daños aún desconocidos de la COVID-19 en la actual pandemia.
Palabras clave: Vasculitis; Púrpura de Schoenlein-Henoch; Infecciones por Coronavirus; Estrongiloidiasis;
Pediatría (fuente: DeCS BIREME).
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INTRODUCTION
Vasculitis is a group of disorders characterized by
inflammation of the walls of blood vessels(1).
Epidemiologically it is a rare disease in children, and
an incidence of 12 to 53 cases per 100,000 of these is
estimated worldwide(2).
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Among the vasculitis, vasculitis associated with the
deposit of IgA, or also called Henoch-Schönlein
purpura (HSP), is the most frequent, followed by
Kawasaki disease.
A condition that has been associated with the
development of vasculitis is the invasion of the vascular
endothelium by Strongyloides stercoralis, which has
mostly been evidenced in cases of hyperinfestations
or severe and systemic conditions generated by this
parasite(3).
Another condition that is still little investigated is the
probable association of IgA vasculitis-like processes
with SARS-CoV-2 infection and COVID-19 itself.
Sustained by an exacerbated IgA-mediated humoral
immune response in COVID-19 cases, predisposing
to the deposit of IgA complexes in the vascular
endothelium, and thus to the development of
vasculitis associated with this immunoglobulin(4).
Thus, in the context of the current pandemic, a case
of IgA vasculitis is reported in a pediatric patient with
COVID-19 and Strongyloidiasis.

CASE REPORT
We present the case of a four-year-old patient, from
the district of Indiana - Loreto, whose parents were
tested positive and treated for COVID-19 a month
earlier. No significant prenatal, natal, and postnatal
history was reported.
Eight days before admission, the patient began with a
high respiratory condition characterized by episodes
of dry cough and rhinorrhea. In the three subsequent
days, recurrent febrile episodes and predominantly
epigastric abdominal pain were added, for which they
administered paracetamol, but since the abdominal
pain did not subside, they took her to the Health
Center, where they prescribed metamizole and
discharged her. due to the increased frecuency and
intensity of the abdominal pain , that same day, she
was self-medicated with piperazine three times.
Two days prior to admission, the mother noted
purplish red punctate and other maculopapular
lesions, predominantly in the lower limbs, plantar
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level of both feet were slightly painful. That day,
she was taken to the Health Center, where she was
hospitalized with severe Dengue diagnoses and
Leptospirosis ruled out. She received treatment with
fluid therapy and ceftriaxone at 60 mg / kg / day.
During her stay at the Health Center, laboratory
tests were requested (Table 1). the initial tendency
to lymphocytopenia was normalized, while the
thrombocytopenia had an increasing tendency,
which ruled out Dengue and Leptospirosis. In the
coproparasitological examination, Strongyloides
stercoralis was observed.
Laboratory tests were performed (Table 1), among
which stood out: IgM and IgG positivity for the
COVID-19 Rapid Test. Between the first and second
CBC, there was a tendency to thrombocytosis. In
addition, a progressive decrease in hemoglobin was
observed, suggestive of a normochromic normocytic
anemia. In the biochemical analyzes, decreased values
of total proteins and albumin were evidenced. Around
the coagulation profile, a prolonged aPTT was found.
On the other hand, the ESR value was increased to 18
mm / hr.
A complete abdominal and renal ultrasound was
performed to rule out acute surgical abdomen, the
result of which was a thickened wall of the cecum
with an inflammatory appearance, without other
significant findings.
Presumptive diagnoses were: 1. COVID-19 IgM
(+) IgG (+), 2. Upper gastrointestinal bleeding 3.
Purpuric syndrome: to rule out IgA vasculitis and 4.
Strongyloidiasis
A liquid diet to tolerance, fluid therapy, ceftriaxone at
80 mg / kg / day every 12 hours, and metronidazole at
40 mg / kg / day every 8 hours, ivermectin at 1 drop /
kg / day for two days, plus omeprazole was indicated.
at 2 mg / kg / day every 12 hours. The defocusing
process also began.
Within the following 36 hours post-hospitalization,
abdominal pain continued with the same intensity
and frequency, an outbreak of new purpuric lesions
on the lower limbs and labial mucosa was identified
(Figure 2), and an episode of hematemesis was
presented.
Once the patient was defocused and with a definitive
diagnosis of IgA vasculitis, corticosteroid therapy
was started with dexamethasone at 0.4 mg / kg / day
every 12 hours for 5 days, and then its equivalent was
replaced with prednisone at 1.5 mg / day. kg / day
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for progressive withdrawal of therapy. In addition,
antibiotic therapy was suspended due to possible
association with exacerbations of this vasculitis.

decrease in abdominal pain and purpuric lesions
(Figure 3). Due to the favorable evolution of the
patient, discharge was indicated.

In the subsequent 48 hours, there was a progressive

CASO CLÍNICO

Figure 1. Upon admission, purpuric lesions in remission, generalized and predominantly of the lower limbs
and plantar region of both feet.
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B

Figure 2. (A) At 36 hours after admission, palpable and mildly painful maculopapular lesions predominantly
in the lower limbs. (B) Petechial lesions on the labial mucosa and soft palate.

Figure 3. On day five of hospitalization, purpuric lesions in lower limbs in remission.
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Table 1. Resultados de laboratorio clínico.
Prior to reference
Laboratory tests

Rank of
reference (*)

Hospitalization

2 days
before admission

1 day before
admission

Day 0

Day 2

5.5 - 15.5

6 550

11.2

8.1

9.4

Granulocytes (%)

40 - 60

71

48

71.5

55.4

Lymphocytes (%)

20 - 40

16

41

25

38.3

Eosinophils (%)

1-4

3

7

3

6

Monocytes (%)

2-8

10

4

6

5

≥ 12.5

12.3

13

11.7

10.6

37

37

39

35.3

35.2

150 - 350

226 x 10

293

415

480

Urea (mg/dL)

22 - 55

-

-

10

-

Creatinine (mg/dL)

0.3 - 0.7

-

-

0.22

-

Blood count
Leukocytes (103/uL)

Hemoglobin (g/dL)

Platelets (103/uL)
Biochemical profile

Aspartate aminotransferase (U/L)

15 - 40

-

-

22

-

Glutamate aminotransferase (U/L)

10 - 35

-

-

5

-

Total proteins (g/dL)

6.4 - 8

-

-

5.1

-

Albumin (g/dL)

3.7 - 5.5

-

-

3.1

-

Proteinuria in 24 hours (mg/dL)

30 - 140

-

-

8.2

-

10

-

-

18

-

Prothrombin time (seg)

12.1 – 14.5

-

-

10.6

-

Activated partial thromboplastin time (seg)

33.6 – 43.8

-

-

44.3

-

0.9 - 1.1

-

-

1.04

-

Clotting time (min seg)

5 - 10

-

-

3 min 30 seg

-

Bleeding Time (min seg)

3-7

-

-

2 min

-

Blood culture

-

-

-

Negative

-

Urine culture

-

-

-

Negative

-

> 20

-

> 100

-

-

-

-

3-5 x field

-

-

-

-

Strongyloides
stercoralis (+)

-

-

SARS-CoV-2 IgM

-

-

-

Reagent

-

SARS-CoV-2 IgG

-

-

-

Reagent

-

Thick Drop:

-

-

-

Negative

-

Serology for Dengue and Leptospirosis:

-

-

-

Non Reactive

-

Globular Sedimentation Rate (mm/h)
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Hematocrit (%)

Coagulation profile

INR

Crops

Coproparasitológico
Leukocytes (x field)
Red blood cells
Parasites
COVID-19 Rapid Test

(*) Reference range in pediatrics.
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DISCUSSION
IgA vasculitis is the most common form of vasculitis
between the ages of 3 and 15, representing
approximately 90% of cases(5, 6).
Regarding the pathophysiology, the characteristic
finding is leukocytoclastic vasculitis accompanied
by immunological IgA complexes within the blood
vessels, mainly post-capillary venules, of the affected
organs(7).

CASO CLÍNICO

Although its cause is still unknown, it has been
associated with a variety of infectious and chemical
triggers, related to a potential increase in serum
levels of IgA immune complexes(8).
One of the triggers that have currently been
hypothesized is COVID-19, which produces different
humoral responses, including the one mediated by IgA
at the systemic and mucosal levels, playing a critical
role in the pathogenesis of COVID-19(4). Supporting
this is the pro-inflammatory and cellular cytotoxicity
effect of IgA on innate immune cells, leading to the
development of autoimmune diseases (9).
It is for this reason that a possible association was
raised between the purpuric lesions due to IgA
vasculitis in our patient, with the immunological
positivity of IgM and IgG for SARS-CoV-2.
On the other hand, the possibility that vasculitis
has been triggered by Strongyloidiasis was
considered a little further away, since this has
mostly occurred according to case reports, when
there are hyperinfestations or severe and systemic
Strongyloidiasis, which is not occurred in the present
case(10).
The laboratory findings were not specific. Cases of
normochromic normocytic anemia associated with
episodes of gastrointestinal bleeding have been
reported, as in our case(11).
Imaging studies are usually done in patients with
significant abdominal symptoms. Abdominal
ultrasound can detect an increase in the thickness of
the intestinal wall, hematomas, peritoneal fluid, and
intussusception(12).
Regarding the diagnosis of IgA vasculitis, this is mainly
based on the clinical manifestations of the disease(13):
palpable purpura without thrombocytopenia or
coagulopathy and two or three of the remaining
clinical characteristics: arthritis/arthralgia, abdominal
pain, and kidney disease.
The patient in the case presented two out of
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four manifestations: palpable purpura with a
predominance in the lower limbs and acute
abdominal pain. Arthralgia, thrombocytopenia, or
any alteration within the renal function profile were
not evidenced.
In the context of pathology studies, in pediatric
patients, the biopsy is reserved for patients with an
unusual presentation of IgA vasculitis, that is, no rash
or an atypical rash, or those with significant kidney
disease.
On treatment, most of the disease is self-limited.
However, the axis of the treatment is adequate
hydration, rest, and symptoms. In case of severe
abdominal or joint pain, the use of corticosteroids
is suggested, these have been shown to shorten the
duration of the pain, but not affect the course of the
disease.
Regarding antibiotic therapy, its use is not suggested,
since drugs such as B-lactams, macrolides, among
others, may be associated with exacerbation
of the case, as happened with our patient, who
was initially administered ceftriaxone thinking
about leptospirosis, which in the following days
exacerbated the condition of purpuric lesions and
abdominal pain(14).
Within the limitations of the case, RT-PCR for SARSCoV-2 was not carried out because there was not
the necessary input for said test. Likewise, another
limitation was that the study of prolonged aPTT
could not be expanded because the test of mixtures
for aPTT was not available in the hospital in that
period, due to the same health crisis that occurred
due to the COVID-19 pandemic.
However, it is important to mention that having
been before a patient with an autoimmune
pathology with prolongation of aPTT, the presence
of lupus anticoagulant and subsequently an
Antiphospholipid Syndrome (APS) or like-APS
possibly induced by COVID-19 should have been
ruled out. and further afield a Systemic Lupus
Erythematosus, the latter being very rare in children
under five years of age. Likewise, it is emphasized
that within the same pathophysiology of COVID-19,
it can occur with both thrombotic and hemorrhagic
coagulopathies, whose risk is even higher than that
of the general population when they are discharged
and evaluated one month). However, the patient
was controlled two and four weeks after discharge,
having laboratory tests within normal ranges,
including the correction of aPTT values.
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It is concluded, having reported the case of a fouryear-old pediatric patient with vasculitis associated
with immunoglobulin A and immunologically
positive for SARS-CoV-2 infection, who responded
favorably to corticosteroid therapy.

After the above, it is recommended to disseminate
this clinical case, since it exposes an infrequent case
in the pediatric population, probably associated with
the still unknown effects and damages that are being
generated by COVID-19 in the current pandemic.
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